Table 4.
Univariate and multivariate analyses of predictors for administration of a recommended antimalarial (SP, amodiaquine or quinine)
| Univariate model* | Multivariate model** | |||||
| Exposure variable | Crude OR | 95% CI | P | Adjusted OR | 95% CI | P |
| Age group | ||||||
| Adult (> 12 years) | 1 | |||||
| Child (< 5 years) | 1.67 | 0.66–4.26 | 0.280 | |||
| Total number of people in household | 0.85 | 0.73–0.99 | 0.041 | 0.79 | 0.64–0.97 | 0.021 |
| Place of illness recognition | ||||||
| Home | 1 | 1 | ||||
| Shamba | 0.19 | 0.07–0.51 | 0.001 | 0.29 | 0.08–1.14 | 0.076 |
| Diarrhoea or vomiting reported | ||||||
| No | 1 | 1 | ||||
| Yes | 5.05 | 1.73–14.74 | 0.003 | 3.24 | 0.85–12.34 | 0.084 |
| Signs of severe malaria | ||||||
| No | ||||||
| Yes | 2.48 | 0.78–7.88 | 0.125 | 3.60 | 0.73–17.86 | 0.117 |
| Illness label (self-defined) | ||||||
| Malaria/degedege | 1 | 1 | ||||
| Homa | 0.10 | 0.04–0.29 | 0.000 | 0.08 | 0.02–0.32 | < 0.001 |
| First action: Antipyretic | ||||||
| No | 1 | |||||
| Yes | 0.61 | 0.17–2.23 | 0.451 | |||
| First action: Traditional medicine | ||||||
| No | 1 | 1 | ||||
| Yes | 0.24 | 0.07–0.81 | 0.022 | 0.08 | 0.01–0.48 | 0.006 |
| Health facility attendance | ||||||
| No | 1 | 1 | ||||
| Yes | 4.46 | 1.69–11.78 | 0.003 | 7.69 | 1.90–31.11 | 0.004 |
| Antimalarial provider in village1 | ||||||
| No | 1 | |||||
| Yes | 2.10 | 0.67–6.59 | 0.201 | |||
| Distance to nearest antimalarial provider (km)***/1 | 0.01 | 0.00–0.43 | 0.017 | |||
| Study area | ||||||
| Ifakara | 1 | |||||
| DSS | 0.22 | 0.05–0.98 | 0.046 | |||
* 137 observations; ** 136 observations; *** 76 observations (DSS only); 1 Incl. health facilities, drug stores and general shops stocking antimalarials in mid-2004